What Is Longevity Science? How Aging Biology Works, What Human Evidence Shows, and Where Claims Break
Longevity science is real. The hard part is knowing which claims have moved from mechanism to human proof.
Longer lives. Better years. What the science actually says.
Longevity science is real. The hard part is knowing which claims have moved from mechanism to human proof.
Longevity will not become serious medicine until it proves what its numbers actually mean.
Rapamycin has real longevity science behind it. That does not make it a proven anti-aging drug for healthy humans.
ER-100 is a narrow eye-disease trial, but it may be the first real test of whether cellular rejuvenation can survive clinical evidence.
Exponential tools are colliding with non-exponential biology.
Longevity does not automatically create planetary collapse. The real burden depends on whether extra years are healthy or dependent, low-carbon or resource-heavy, shared or stratified.
Epigenetic clocks can be useful research tools and decent trend signals. They become dangerous when people treat them like destiny.
NMN and NR can move NAD-related biomarkers. That does not mean they have already proved meaningful anti-aging outcomes in humans.
UBX1325 is one of the clearest tests yet of whether senolytics can move from longevity mythology into real medicine.
The future of reprogramming depends less on ambition than on control.
Sinclair changed how longevity talks about aging. The hard question is how much of the theory will survive clinical reality.
ER-100 matters because rejuvenation language is finally being forced to answer to medicine.